RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+20.34%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.16B
AUM Growth
+$4.16B
(+7.4%)
Cap. Flow
+$89.8M
Cap. Flow
% of AUM
2.16%
Top 10 Holdings %
Top 10 Hldgs %
34.47%
Holding
128
New
1
Increased
41
Reduced
25
Closed
8
Top Buys
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$42.5M |
| 2 |
Amylyx Pharmaceuticals
AMLX
|
$30.5M |
| 3 |
Baxter International
BAX
|
$20.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$16.5M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$15.5M |
Top Sells
| 1 |
CVET
Covetrus, Inc. Common Stock
CVET
|
$35.1M |
| 2 |
Talphera
TLPH
|
$13.6M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$13.4M |
| 4 |
Arvinas
ARVN
|
$12.5M |
| 5 |
OHPAU
Orion Acquisition Corp. Unit
OHPAU
|
$9.87M |
Sector Composition
| 1 | Healthcare | 97.81% |
| 2 | Consumer Staples | 0.83% |
| 3 | Industrials | 0.36% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sarepta Therapeutics
SRPT
$1.78B
| $56.5M | 1.36% | 436,000 +6,000 | +1% | +$777K |
|
27
DexCom
DXCM
$29.5B
| $55.5M | 1.34% | 490,500 | – | – |
|
28
Ascendis Pharma
ASND
$11.8B
| $52M | 1.25% | 425,500 | – | – |
|
|
SGEN
29
DELISTED
Seagen Inc. Common Stock
SGEN
| $51.4M | 1.24% | 400,200 +128,200 | +47% | +$16.5M |
|
30
Rhythm Pharmaceuticals
RYTM
$6.85B
| $51.3M | 1.23% | 1,760,865 | – | – |
|
31
Edwards Lifesciences
EW
$47.8B
| $48.2M | 1.16% | 645,900 +14,900 | +2% | +$1.11M |
|
32
Xenon Pharmaceuticals
XENE
$2.98B
| $46.4M | 1.12% | 1,175,672 +19,711 | +2% | +$777K |
|
|
33
Amylyx Pharmaceuticals
AMLX
$836M
| $45.4M | 1.09% | 1,229,637 +825,900 | +205% | +$30.5M |
|
34
Prothena Corp
PRTA
$441M
| $45.4M | 1.09% | 753,462 +75,000 | +11% | +$4.52M |
|
35
Exact Sciences
EXAS
$8.98B
| $43.9M | 1.06% | 887,500 +308,900 | +53% | +$15.3M |
|
36
West Pharmaceutical
WST
$17.8B
| $43.7M | 1.05% | 185,500 +5,000 | +3% | +$1.18M |
|
|
NVRO
37
DELISTED
NEVRO CORP.
NVRO
| $42.7M | 1.03% | 1,077,900 +290,900 | +37% | +$11.5M |
|
38
Phreesia
PHR
$1.88B
| $42.1M | 1.01% | 1,302,500 | – | – |
|
39
Pacira BioSciences
PCRX
$1.2B
| $39.9M | 0.96% | 1,032,600 +15,100 | +1% | +$583K |
|
|
OLK
40
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $36.7M | 0.88% | 1,445,000 | – | – |
|
|
MRTX
41
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $36.5M | 0.88% | 805,024 -61,752 | -7% | -$2.8M |
|
42
Mirum Pharmaceuticals
MIRM
$3.71B
| $35M | 0.84% | 1,795,733 | – | – |
|
43
Freshpet
FRPT
$2.72B
| $34.7M | 0.83% | 657,000 -43,000 | -6% | -$2.27M |
|
|
ABCM
44
DELISTED
Abcam plc American Depositary Shares
ABCM
| $33.9M | 0.82% | 2,180,000 +147,500 | +7% | +$2.3M |
|
45
Zai Lab
ZLAB
$3.68B
| $32.5M | 0.78% | 1,059,700 -132,700 | -11% | -$4.07M |
|
46
Kymera Therapeutics
KYMR
$2.95B
| $30.6M | 0.74% | 1,227,779 +181,036 | +17% | +$4.52M |
|
47
iRhythm Technologies
IRTC
$5.46B
| $29M | 0.7% | 309,450 +16,200 | +6% | +$1.52M |
|
48
BioMarin Pharmaceuticals
BMRN
$11.2B
| $27.4M | 0.66% | 264,500 | – | – |
|
49
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $27.2M | 0.65% | 200,000 | – | – |
|
50
Compass Therapeutics
CMPX
$483M
| $26.8M | 0.65% | 5,333,188 | – | – |
|